Spyroglou A, Handgriff L, Müller L, Schwarzlmüller P, Parasiliti-Caprino M, Fuss CT, Remde H, Hirsch A, O’Toole SM, Thuzar M, Petramala L, Letizia C, Deflorenne E, Amar L, Vrckovnik R, Kocjan T, Zhang CD, Li D, Singh S, Katabami T, Yoneda T, Murakami M, Wada N, Inagaki N, Quinkler M, Ghigo E, Maccario M, Stowasser M, Drake WM, Fassnacht M, Bancos I, Reincke M, Naruse M, Beuschlein F The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex – a multicenter-study of 3566 Caucasian and Asian subjects
Eur J Endocrinol 187(3):361-372
Ie K, Ishizuka K, Sakai T, Motohashi I, Asai S, Okuse C Subacute Thyroiditis Developing Within 2 Days of Vaccination Against COVID-19 with BNT162b2 mRNA
European Journal of Case Reports in Internal Medicine 10(1):003735
Kobayashi H, Nakamura Y, Abe M, Tanabe A, Sone M, Katabami T, Kurihara I, Ichijo T, Tsuiki M, Izawa S, Wada N, Yoneda T, Takahashi K, Impact of a change to a novel chemiluminescent immunoassay for measuring plasma aldosterone on the diagnosis of primary aldosteronism
Endocrine Journal 32(9-10):237-245
Karashima S, Kawakami M, Nambo H, Kometani M, Kurihara I, Ichijo T, Katabami T, Tsuiki M, Wada N, Oki K, Ogawa Y, Okamoto R, Tamura K, A hyperaldosteronism subtypes predictive model using ensemble learning.
Sci Rep 46(3):13(1):3043
Nakamura Y, Takemoto A, Oyanagi T, Tsunemi S, Kubo Y, Nakagawa T, Nagai Y, Tanaka Y, Sone M, Effects of cooked rice containing high resistant starch on postprandial plasma glucose, insulin, and incretin in patients with type 2 diabetes
Asia Pac J Clin Nutr 32(1):48-56
Ohno Y, Taura D, Okamoto K, Fujita H, Honda-Kohmo K, Matsuo K, Sone M Nicotine reduces ROS and enhances cell proliferation via the α4 nicotinic acetylcholine receptor subunit in human induced pluripotent stem
Stem Cells Dev 32(9-10):237-245
Yokota K, Sone M Autonomous cortisol secretion in patients with primary aldosteronism: A possible risk factor for new-onset diabetes mellitus
Hypertens Res 46(3):803-805, 2023
Yokota K, Shibata H, Kurihara I, Itoh H, Sone M CASZ1: a promising factor modulating aldosterone biosynthesis and mineralocorticoid receptor activity
Hypertens Res 46(2):417-420, 2023
Kano M, Sasaki H, Miwata T, Suga H Recipe for pituitary organoids
Front Endocrinol 13:1025825, 2023
Kawanabe S, Katabami T, Oshima R, Yanagisawa N, Sone M, Kimura N A rare case of multiple paragangliomas in the head and neck, retroperitoneum and duodenum: A case report and review of the literature
Front Endocrinol 13:1054468, 2023
Akter S, Shimba A, Ikuta K, Mahmud MRA, Yamada S, Sasanuma H, Tsuda M, Sone M, Ago Y, Murai K, Tanaka H, Takeda S Physiological concentrations of glucocorticoids induce pathological DNA double-strand breaks
Genes Cells 28(1):53-67, 2023
Naruse M, Murakami M, Katabami T, Kocjan T, Parasiliti-Caprino M, Quinkler M, St-Jean M, O’Toole S, Ceccato F, Kraljevic I, Kastelan D, Tsuiki M, Deinum J, Torre EM, Puar T, Markou A, Piaditis G, Laycock K, Wada N, Grytaas MA, Kobayashi H, Tanabe A, Tong CV, Gallego NV, Gruber S, Beuschlein F, Kürzinger L, Sukor N, Azizan EABA, Ragnarsson O, Nijhoff MF, Maiolino G, Dalmazi GD, Kalugina V, Lacroix A, Furnica RM, Suzuki T International multicenter survey on screening and confirmatory testing in primary aldosteronism
Eur J Endocrinol 188(1):lvac002, 2023
Jo R, Shibata H, Kurihara I, Yokota K, Kobayashi S, Murai-Takeda A, Mitsuishi Y, Hayashi T, Nakamura T, Itoh H Mechanisms of mineralocorticoid receptor-associated hypertension in diabetes mellitus: the role of O-GlcNAc modification
Hypertens Res 46(1):19-31, 2023
2022年
Spyroglou A, Handgriff L, Müller L, Schwarzlmüller P, Parasiliti-Caprino M, Fuss CT, Remde H, Hirsch A, O’Toole SM, Thuzar M, Petramala L, Letizia C, Deflorenne E, Amar L, Vrckovnik R, Kocjan T, Zhang CD, Li D, Singh S, Katabami T, The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex – a multicenter-study of 3566 Caucasian and Asian subjects 187(3):361-372
Katabami T, Matsuba R, Kobayashi H, Nakagawa T, Kurihara I, Ichijo T, Tsuiki M, Wada N, Ogawa Y, Sone M, Inagaki N, Yoshimoto T, Takahashi K, Yamamoto K, Izawa S, Kakutani M, Tanabe A, Naruse M Primary aldosteronism with mild autonomous cortisol secretion increases renal complication risk 186(6):645-655
Ozaki H, Suga H, Sakakibara M, Soen M, Miyake N, Miwata T, Taga S, Nagai T, Kano M, Mitsumoto K, Miyata T, Kobayashi T, Sugiyama M, Onoue T, Takagi H, Hagiwara D, Iwama S, Banno R, Iguchi G, Takahashi Y, Muguruma K, Inoue H, Arima H Differentiation of human induced pluripotent stem cells into hypothalamic vasopressin neurons with minimal exogenous signals and partial conversion to the naive state
Sci Rep 12:17381, 2022
Ishii T, Kashimada K, Amano N, Takasawa K, Nakamura-Utsunomiya A, Yatsuga S, Mukai T, Ida S, Isobe M, Fukushi M, Satoh H, Yoshino K, Otsuki M, Katabami T, Tajima T Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision)
Clin Pediatr Endocrinol 31(3):116-143, 2022
Haze T, Yano Y, Hatano Y, Tamura K, Kurihara I, Kobayashi H, Tsuiki M, Ichijo T, Wada N, Katabami T, Yamamoto K, Okamura S, Kai T, Izawa S, Yoshikawa Y, Yamada M, Chiba Y, Tanabe A, Naruse M, JPAS/JRAS Study Group Association of achieved blood pressure after treatment for primary aldosteronism with long-term kidney function
J Hum Hypertens 36(10):904-910, 2022
Hishida Y, Nagai Y, Tsukiyama H, Nakamura Y, Nakagawa T, Ishizaki S, Tanaka Y, Sone M Effects of Elobixibat in Patients with Diabetesand Concomitant Chronic Constipation: an 8-week,Prospective, Single-center, Single-arm Study
Adv Ther 39(9):4205-4217, 2022
Nomura M, Kurihara I, Itoh H, Ichijo T, Katabami T, Tsuiki M, Wada N, Yoneda T, Sone M, Oki K, Yamada T, Kobayashi H, Tamura K, Ogawa Y, Inagaki N, Yamamoto K, Otsuki M, Yabe D, Izawa S, Takahashi Y, Suzuki T, Yasoda A, Tanabe A, Naruse M; JPAS/JRAS Study Group. Association of cardiovascular disease risk and changes in renin levels by mineralocorticoid receptor antagonists in patients with primary aldosteronism
Hypertens Res 45(9):1476-1485, 2022
Tsunemi S, Nakamura Y, Yokota K, Nakagawa T, Tsukiyama H, Kubo Y, Oyanagi T, Takemoto A, Nagai Y, Tanaka Y, Sone M Correlation between blood ketones and exhaled acetone measured with a semiconducting gas sensor
J Breath Res 16(4):10.1088/1752-7163/ac836a, 2022
Kano M, Mizutani E, Homma S, Masaki H, Nakauchi H Xenotransplantation and interspecies organogenesis: current status and issues
Front Endocrinol 13:963282, 2022
Kometani M, Yoneda T, Karashima S, Takeda Y, Tsuiki M, Yasoda A, Kurihara I, Wada N, Katabami T, Sone M, Ichijo T, Tamura K, Ogawa Y, Kobayashi H, Okamura S, Inagaki N, Kawashima J, Fujita M, Oki K, Matsuda Y, Tanabe A, Naruse M Effect of Intraprocedural Cortisol Measurement on ACTH-stimulated Adrenal Vein Sampling in Primary Aldosteronism
J Endocr Soc 6(9):bvac104, 2022
Katabami T, Matsuba R, Kobayashi H, Nakagawa T, Kurihara I, Ichijo T, Tsuiki M, Wada N, Ogawa Y, Sone M, Inagaki N, Yoshimoto T, Takahashi K, Yamamoto K, Izawa S, Kakutani M, Tanabe A, Naruse M Primary aldosteronism with mild autonomous cortisol secretion increases renal complication risk
Eur J Endocrinol 186(6):645-655, 2022
Spyroglou A, Handgriff L, Müller L, Schwarzlmüller P, Parasiliti-Caprino M, Fuss CT, Remde H, Hirsch A, O’Toole SM, Thuzar M, Petramala L, Letizia C, Deflorenne E, Amar L, Vrckovnik R, Kocjan T, Zhang CD, Li D, Singh S, Katabami T, Yoneda T, Murakami M, Wada N, Inagaki N, Quinkler M, Ghigo E, Maccario M, Stowasser M, Drake WM, Fassnacht M, Bancos I, Reincke M, Naruse M, Beuschlein F The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex – a multicenter-study of 3566 Caucasian and Asian subjects
Eur J Endocrinol 187(3):361-372, 2022
Naruse M, Katabami T, Shibata H, Sone M, Takahashi K, Tanabe A, Izawa S, Ichijo T, Otsuki M, Omura M, Ogawa Y, Oki Y, Kurihara I, Kobayashi H, Sakamoto R, Satoh F, Takeda Y, Tanaka T, Tamura K, Tsuiki M, Hashimoto S, Hasegawa T, Yoshimoto T, Yoneda T, Yamamoto K, Rakugi H, Wada N, Saiki A, Ohno Y, Haze T Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021
Endocr J 69(4):327-359, 2022
Izawa S, Matsumoto K, Matsuzawa K, Katabami T, Yoshimoto T, Otsuki M, Sone M, Takeda Y, Okamura S, Ichijo T, Tsuiki M, Suzuki T, Naruse M, Tanabe A Sex Difference in the Association of Osteoporosis and Osteopenia Prevalence in Patients with Adrenal Adenoma and Different Degrees of Cortisol Excess
Int J Endocrinol 2022:5009395, 2022
Kohata N, Kurihara I, Yokota K, Kobayashi S, Murai-Takeda A, Mitsuishi Y, Nakamura T, Morisaki M, Kozuma T, Torimitsu T, Kawai M, Hiroshi I Lysine-specific demethylase 1 as a corepressor of mineralocorticoid receptor
Hypertens Res 45(4):641-649, 2022
Katabami T, Eriksen KT, Yamamoto Y, Ishigaki Y Long-Term Safety and Clinical Outcomes with Insulin Degludec/Insulin Aspart Treatment in Japanese Patients with Diabetes: A Real-World, Prospective, Observational Study
Adv Ther 39(1):544-561, 2022
Yokota K, Kurihara I, Nakamura T, Nakatsuka S, Miyashita K, Kobayashi S, Murai-Takeda A, Sone M, Itoh H Remission of Angiographically Confirmed Minocycline-induced Renal Polyarteritis Nodosa: A Case Report and Literature Review
Intern Med 61(1):103-110, 2022
2021年
Hishida Y, Nakamura Y, Tsukiyama H, Nakagawa T, Sone M A retrospective cohort study for the treatment of Asian diabetic ketoacidosis: optimizing initial doses of insulin
Acute Med Surg 8(1):e721, 2021
Kimura N, Shiga K, Kaneko K, Oki Y, Sugisawa C, Saito J, Tawara S, Akahori H, Sogabe S, Yamashita T, Takekoshi K, Naruse M, Katabami T Immunohistochemical Expression of Choline Acetyltransferase and Catecholamine‑Synthesizing Enzymes in Head‑and‑Neck and Thoracoabdominal Paragangliomas and Pheochromocytomas
Endocr Pathol 32(4):442-451, 2021
Saito K, Kurihara I, Itoh H, Ichijo T, Katabami T, Tsuiki M, Wada N, Yoneda T, Sone M, Oki K, Yamada T, Kobayashi H, Tamura K, Ogawa Y, Kawashima J, Inagaki N, Yamamoto K, Yamada M, Kamemura K, Fujii Y, Suzuki T, Yasoda A, Tanabe A, Naruse M, Japan Primary Aldosteronism Study/Japan Rare Intractable Adrenal Diseases Study Group Subtype-specific trends in the clinical picture of primary aldosteronism over a 13-year period
J Hypertens 39(11):2325-2332, 2021
Kawashima A, Sone M, Inagaki N, Okamoto K, Tsuiki M, Izawa S, Otsuki M, Okamura S, Ichijo T, Katabami T, Takeda Y, Yoshimoto T, Naruse M, Tanabe A Pheochromocytoma and paraganglioma with negative results for urinary metanephrines show higher risks for metastatic diseases
Endocrine 74(1):155-162, 2021
Yokota K, Kurihara I, Matsusaka Y, Emoto K, Hishida T, Oshida T, Kobayashi S, Murai-Takeda A, Miyashita K, Matsuda K, Nakagomi T, Matsuda K, Itoh H Mediastinal Cystic Parathyroid Adenoma Diagnosed by Somatostatin Receptor Scintigraphy
Intern Med 60(10):1555-1560, 2021
Yokota K, Shibata H, Kurihara I, Kobayashi S, Muraii-Takeda A, Itoh H CASZ1b is a novel transcriptional corepressor of mineralocorticoid receptor
Hypertens Res 44(4):407-416, 2021
Haze T, Hirawa N, Yano Y, Tamura K, Kurihara I, Kobayashi H, Tsuiki M, Ichijo T, Wada N, Katabami T, Yamamoto K, Oki K, Inagaki N, Okamura S, Kai T, Izawa S, Yamada M, Chiba Y, Tanabe A, Naruse M Association of aldosterone and blood pressure with the risk for cardiovascular events after treatments in primary aldosteronism
Atherosclerosis 324:84-90, 2021
Okamoto K, Ohno Y, Sone M, Inagaki N, Ichijo T, Yoneda T, Tsuiki M, Wada N, Oki K, Tamura K, Kobayashi H, Izawa S, Tanabe A, Naruse M Should Adrenal Venous Sampling Be Performed in PA Patients Without Apparent Adrenal Tumors?
Front Endocrinol 12:645395, 2021
Nishimoto K, Umakoshi H, Seki T, Yasuda M, Araki R, Otsuki M, Katabami T, Shibata H, Ogawa Y, Wada N, Sone M, Okamura S, Izawa S, Miyauchi S, Yoshimoto T, Tsuiki M, Naruse M, JRAS Study Group Diverse pathological lesions of primary aldosteronism and their clinical significance
Hypertens Res 44(5):498-507, 2021
Nakamaru R, Yamamoto K, Akasaka H, Rakugi H, Kurihara I, Yoneda T, Ichijo T, Katabami T, Tsuiki M, Wada N, Yamada T, Kobayashi H, Tamura K, Ogawa Y, Kawashima J, Inagaki N, Fujita M, Watanabe M, Kamemura K, Okamura S, Tanabe A, Naruse M, JPAS/JRAS Study Group Age-stratified comparison of clinical outcomes between medical and surgical treatments in patients with unilateral primary aldosteronism
Sci Rep 11(1):6925, 2021
Nakamaru R, Yamamoto K, Akasaka H, Rakugi H, Kurihara I, Yoneda T, Ichijo T, Katabami T, Tsuiki M, Wada N, Yamada T, Kobayashi H, Tamura K, Ogawa Y, Kawashima J, Inagaki N, Fujita M, Oki K, Kamemura K, Tanabe A, Naruse M, JPAS/JRAS study group Sex Differences in Renal Outcomes After Medical Treatment for Bilateral Primary Aldosteronism
Hypertension 77(2):537-545, 2021
Yasuda T, Murakami T, Yasoda A, Sone M, Norio H, Ogura M, Inagaki N Clinical Practice Changes After Post-Market Safety Reports on Desmopressin Orally Disintegrating Tablet in Japan: A Single-Center Retrospective Study
J Clin Med Res 13(2):92-100, 2021
Yamamoto Y, Nagai Y, Kawanabe S, Hishida Y, Hiraki K, Sone M, Tanaka Y Effects of resistance training using elastic bands on muscle strength with or without a leucine supplement for 48 weeks in elderly patients with type 2 diabetes
Endocr J 68(3):291-298, 2021
Takao K, Iizuka K, Liu Y, Sakurai T, Kubota S, Kubota-Okamoto S, Imaizumi T, Takahashi Y, Rakhat Y, Komori S, Hirose T, Nonomura K, Kato T, Mizuno M, Suwa T, Horikawa Y, Sone M, Yabe D Effects of ChREBP deficiency on adrenal lipogenesis and steroidogenesis
J Endocrinol 248(3):317-324, 2021
Ohno Y, Naruse M, Beuschlein F, Schreiner F, Parasiliti-Caprino M, Deinum J, Drake WM, Fallo F, Fuss CT, Grytaas MA, Ichijo T, Inagaki N, Kakutani M, Kastelan D, Kraljevic I, Katabami T, Kocjan T, Monticone S, Mulatero P, O’Toole S, Kobayashi H, Sone M, Tsuiki M, Wada N, Williams TA, Reincke M, Tanabe A Adrenal venous sampling guided adrenalectomy rates in primary aldosteronism: results of an international cohort (AVSTAT)
J Clin Endocrinol Metab 106(3):e1400-e1407, 2021
Hiruma M, Sasano Y, Watanabe N, Yoshihara A, Ishii S, Yaguchi Y, J Yoshimura N, Sugino K, Ito K Propylthiouracil-induced otitis media with antineutrophil cytoplasmic antibody-associated vasculitis: a case report and review of the literature
Endocr J 68(2):145-151, 2021
2020年
Kimura N, Shiga K, Kaneko K, Sugisawa C, Katabami T, Naruse M The Diagnostic Dilemma of GATA3 Immunohistochemistry in Pheochromocytoma and Paraganglioma
Endocr Pathol 31(2):95-100, 2020
Nakayama T, Nagai Y, Yasunaka Y, Uraguchi T, Wada Y, Sone M, Tanaka Y Effect of Eating Glutinous Brown Rice Twice a Day for 6 Weeks on Serum 1,5-Anhydroglucitol in Japanese Subjects without Diabetes
J Nutr Metab 2020:8847781
Imai T, Shibata S, Shinohara K, Sakurai K, Horiuchi M, Sakai K, Asai S, Hasegawa Y IgG4-related hypophysitis diagnosed by retroperitoneal mass biopsy in a patient presenting with abducens nerve palsy
Medicine 99(40):e22484, 2020
Katabami T, Tsukiyama H, Tanabe M, Matsuba R, Murakami M, Nishine A, Shimizu S, Sakai K, Tanaka Y & Yanase T Development of a simple prediction model for adrenal crisis diagnosis
Sci Rep 10(1):13546, 2020
Kobayashi Y, Haze T, Yano Y, Tamura K, Kurihara I, Ichijo T, Yoneda T, Katabami T, Tsuiki M, Wada N, Ogawa Y, Kawashima J, Sone M, Inagaki N, Yamada T, Okamoto R, Fujita M, Kamemura K, Yamamoto K, Izawa S, Tanabe A and Naruse M and JPAS/JRAS Study Group Associations Between Changes in Plasma Renin Activity and Aldosterone Concentrations and Changes in Kidney Function After Treatment for Primary Aldosteronism
Kidney Int Rep 5(8):1291-1297, 2020
Yamasaki Y, Ooka S, Tsuchida T, Nakamura Y, Hagiwara Y, Naitou Y, Ishibashi Y, Ikeda H, Sakurada T, Handa H, Nishine H, Takita M, Morikawa D, Yoshida H, Fujii S, Morisawa K, Takemura H, Fujitani S, Kunishima H The peripheral lymphocyte count as a predictor of severe COVID-19 and the effect of treatment with ciclesonide
Virus Res 290:198089, 2020
Ohno Y, Sone M, Inagaki N, Kawashima A, Takeda Y, Yoneda T, Kurihara I, Itoh H, Tsuiki M, Ichijo T, Katabami T, Wada N, Sakamoto R, Ogawa Y, Yoshimoto T, Yamada T, Kawashima J, Matsuda Y, Kobayashi H, Kamemura K, Yamamoto K, Otsuki M, Okamura S, Izawa S, Okamoto R, Tamura K, Tanabe A, Naruse M; JPAS/JRAS Study Group Nadir Aldosterone Levels After Confirmatory Tests Are Correlated With Left Ventricular Hypertrophy in Primary Aldosteronism
Hypertension 75(6):1475-1482, 2020
Naruse M, Yamamoto K, Katabami T, Nakamaru R, Sone M, Kobayashi H, Tanabe A Age, Gender, and Body Mass Index as Determinants of Surgical Outcome in Primary Aldosteronism
Horm Metab Res 52(6):454-458, 2020
Tsujimoto H, Kasahara T, Sueta SI, Araoka T, Sakamoto S, Okada C, Mae SI, Nakajima T, Okamoto N, Taura D, Nasu M, Shimizu T, Ryosaka M, Li Z, Sone M, Ikeya M, Watanabe A, Osafune K. A Modular Differentiation System Maps Multiple Human Kidney Lineages from Pluripotent Stem Cells
Cell Rep 31(1):107476, 2020
Saiki A, Otsuki M, Tamada D, Kitamura T, Shimomura I, Kurihara I, Ichijo T, Takeda Y, Katabami T, Tsuiki M, Wada N, Yanase T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Yoshimoto T, Okamoto R, Takahashi K, Kobayashi H, Tamura K, Kamemura K, Yamamoto K, Izawa S, Kakutani M, Yamada M, Tanabe A, Naruse M Diabetes Mellitus Itself Increases Cardio-Cerebrovascular Risk and Renal Complications in Primary Aldosteronism
J Clin Endocrinol Metab 105(7):dgaa177, 2020
Taura D, Nakao K, Nakagawa Y, Kinoshita H, Sone M, Nakao K C-type natriuretic peptide (CNP)/guanylate cyclase B (GC-B) system and endothelin-1(ET-1)/ET receptor A and B system in human vasculature
Can J Physiol Pharmacol 98(9):611-617, 2020
Nakamaru R, Yamamoto K, Rakugi H, Akasaka H, Kurihara I, Ichijo T, Takeda Y, Katabami T, Tsuiki M, Wada N, Ogawa Y, Kawashima J, Sone M, Yoshimoto T, Okamoto R, Fujita M, Kobayashi H, Tamura K, Kamemura K, Okamura S, Kakutani M, Tanabe A, Naruse M; JPAS/JRAS Study Group Obesity predicts persistence of resistant hypertension after surgery in patients with primary aldosteronism
Clin Endocrinol (Oxf) 93(3):229-237, 2020
Hatoko T, Murakami T, Sone M, Yabe D, Masui T, Nakamoto Y, Furuta A, Uza N, Kodama Y, Harada N, Ogura M, Yasoda A, Inagaki N Low-dose Selective Arterial Calcium Stimulation Test for Localizing Insulinoma: A Single-center Experience of Five Consecutive Cases
Intern Med 59(19):2397-2403, 2020
Saiki A, Otsuki M, Mukai K, Hayashi R, Shimomura I, Kurihara I, Ichijo T, Takeda Y, Katabami T, Tsuiki M, Wada N, Ogawa Y, Kawashima J, Sone M, Inagaki N, Yoshimoto T, Okamoto R, Takahashi K, Kobayashi H, Tamura K, Kamemura K, Yamamoto K, Izawa S, Kakutani M, Yamada M, Tanabe A, Naruse M, JPAS/JRAS Study Group Basal Plasma Aldosterone Concentration Predicts Therapeutic Outcomes in Primary Aldosteronism
J Endocr Soc 4(4):1-12, 2020
Kobayashi H, Nakamura Y, Abe M, Kurihara I, Itoh H, Ichijo , Takeda Y, Yoneda T, Katabami T, Tsuiki M, Wada N, Ogawa Y, Sakamoto R, Kawashima J, Sone M, Inagaki N, Yoshimoto T, Yamada T, Okamoto R, Matsuda Y, Fujita M, Watanabe M, Tamura K, Tanabe A, Naruse M, JPAS/JRAS Study Group Effect of cosyntropin during adrenal venous sampling on subtype of primary aldosteronism: analysis of surgical outcome
Eur J Endocrinol 182(3):265-273, 2020
Ishii S, Nagai Y, Kato H, Fukuda H, Tanaka Y Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin on Muscle Mass and the Muscle/Fat Ratio in Patients With Type 2 Diabetes
J Clin Med Res 12(2):122-126, 2020
2019年
Nakagawa T, Nagai Y, Yamamoto Y, Miyachi A, Hamajima H, Mieno E, Takahashi M, Inoue E, Tanaka Y Effects of anagliptin on plasma glucagon levels and gastric emptying in patients with type 2 diabetes: an exploratory randomized controlled trial versus metformin
Diabetes Res Clin Pract 158:107892, 2019
Morisaki M, Kurihara I, Itoh H, Naruse M, Takeda Y, Katabami T, Ichijo T, Wada N, Yoshimoto T, Ogawa Y, Sone M, Tsuiki M, Shibata H, Kawashima J, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Suzuki T, JPAS Study Group Predictors of Clinical Success After Surgery for Primary Aldosteronism in the Japanese Nationwide Cohort
J Endocr Soc 3:2012-2022, 2019
Kyo C, Usui T, Kosugi R, Torii M, Yonemoto T, Ogawa T, Kotani M, Tamura N, Yamamoto Y, Katabami T, Kurihara I, Saito K, Kanamoto N, Fukuoka H, Wada N, Murabe H, Inoue T ARMC5 Alterations in Primary Macronodular Adrenal Hyperplasia (PMAH) and the Clinical State of Variant Carriers
J Endocr Soc 3:1837-1846, 2019
Takekoshi K, Satoh F, Tanabe A, Okamoto T, Ichihara A, Tsuiki M, Katabami T, Nomura , Tanaka T,Matsuda T, Imai T, Yamada M, Asada S, Kawata N, Naruse M Correlation between urinary fractionated metanephrines in 24-hour and spot urine samples for evaluating the therapeutic effect of metyrosine: a subanalysis of a multicenter, open-label phase I/II study
Endocr J 66:1063-1072, 2019
Fujii Y, Takeda Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Yamamto K, Ogo A, Yanase T, Okamura S, Miyauchi S, Fujita M, Suzuki T, Umakoshi H, Ogasawara T, Tsuiki M, Naruse M, JPAS Study Group Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan
J Hum Hypertens 34:34-42, 2020
Kawashima A, Sone M, Inagaki N, Takeda Y, Itoh H, Kurihara I, Umakoshi , Ichijo , Katabami T, Wada N, Ogawa Y, Kawashima J, Fujita M, Miyauchi S, Okamura S, Fukuoka T, Yanase T, Izawa S, Yoshikawa Y, Hashimoto S, Yamada M, Kai T, Suzuki T, Naruse M Renal impairment is closely associated with plasma aldosterone concentration in patients with primary aldosteronism
Eur J Endocrinol 181:339-350, 2019
Ohno Y, Sone M, Inagaki N, Takeda Y, Kurihara I, Tsuiki M, Ichijo T, Wada N, Katabami T, Ogawa Y, Okamura S, Fukuoka T, Kai T, Izawa S, Yoshikawa Y, Hashimoto S, Yamada M, Chiba Y, Naruse M, JPAS/JRAS Study Group Latent Autonomous Cortisol Secretion From Apparently Nonfunctioning Adrenal Tumor in Nonlateralized Hyperaldosteronism
J Clin Endocrinol Metab 104:4382-4389, 2019
Kobayashi H, Abe M, Nakamura Y, Takahashi K, Fujita M, Takeda Y, Yoneda T, Kurihara I, Itoh H, Tsuiki M, Wada N, Ichijo T, Katabami T, Ogawa Y, Kawashima J, Yoshimoto T, Sone M, Inagaki N, Watanabe M, Kamemura K, Matsuda Y, Izawa S, Tanabe M, Tanabe A, Suzuki T, Naruse M, JPAS/JRAS Study Group Association Between Acute Fall in Estimated Glomerular Filtration Rate After Treatment for Primary Aldosteronism and Long-Term Decline in Renal Function
Hypertension 74:630-638, 2019
Akasaka H, Yamamoto K, Rakugi H, Nagasawa M, Nakamaru R, Ichijo T, Takeda Y, Kurihara I, Katabami T, Tsuiki M, Wada N, Ogawa Y, Kawashima J, Sone M, Kamemura K, Yoshimoto T, Matsuda Y, Fujita M, Kobayashi H, Watanabe M, Tamura K, Okamura S, Miyauchi S, Izawa S, Chiba Y, Tanabe A, Naruse M, Japan Primary Aldosteronism Study Group Sex Difference in the Association Between Subtype Distribution and Age at Diagnosis in Patients With Primary Aldosteronism
Hypertension 74:368-374, 2019
Wada N, Shibayama Y, Yoneda T, Katabami T, Kurihara I, Tsuiki M, Ichijo T, Ogawa Y, Kawashima J, Sone M, Yoshimoto T, Matsuda Y, Fujita M, Kobayashi H, Tamura K, Kamemura K, Otsuki M, Okamura S, Naruse M, JPAS/JRAS Study Group Lateralizing Asymmetry of Adrenal Imaging and Adrenal Vein Sampling in Patients With Primary Aldosteronism
J Endocr Soc 3:1393-1402, 2019
Nagai Y, Fukuda H, Kawanabe S, Nakagawa T, Ohta A, Tanaka Y Differing Effect of the Sodium-Glucose Contransporter 2 Inhibitor Ipragliflozin on the Decrease of Fat Mass vs. Learn Mass in Patients With or Without Metformin Therapy
J Clin Med Res 11:297-300, 2019
Nakamura Y, Nagai Y, Toshio K, Furukawa K, Oikawa Y, Shimada A, Tanaka Y Characteristics of Gut Microbiota in Patients With Diabetes Determined by Data Mining Analysis of Terminal Restriction Fragment Length Polymorphisms
J Clin Med Res 11:401-406, 2019
Takeda Y, Umakoshi H, Takeda Y, Yoneda T, Kurihara I, Katabami T, Ichijo T, Wada N, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamto K, Ogo A, Yanase T, Suzuki T, Naruse M; JPAS Study Group. Impact of adrenocorticotropic hormone stimulation during adrenal venous sampling on outcomes of primary aldosteronism
J Hypertens 37:1077-1082, 2019
Ishii S, Nagai Y, Sada Y, Fukuda H, Nakamura Y, Matsuba R, Nakagawa T, Kato H, Tanaka Y Liraglutide Reduces Visceral and Intrahepatic Fat Without Significant Loss of Muscle Mass in Obese Patients With Type 2 Diabetes: A Prospective Case Series
J Clin Med Res 11:219-224, 2019
Kawanabe S, Nagai Y, Nakamura Y, Nishine A, Nakagawa T, Tanaka Y Association of the muscle/fat mass ratio with insulin resistance in gestational diabetes mellitusEndocr J 66:75-80, 2019
Katabami T, Fukuda H, Tsukiyama H, Tanaka Y, Takeda Y, Kurihara I, Ito H, Tsuiki M, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Yanase T,Suzuki T, and Naruse M, JPAS/JRAS Study Group Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism
J Hypertens 37:1513-1520, 2019
Akehi Y, Yanase T, Motonaga R, Umakoshi H, Tsuiki M, Takeda Y, Yoneda T, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ashida K, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Hashimoto S, Yamada M, Yoshikawa Y, Kai T, Suzuki T, Kawamura T,and Naruse M, Japan Primary Aldosteronism Study Group High Prevalence of Diabetes in Patients With Primary Aldosteronism (PA) Associated With Subclinical Hypercortisolism and Prediabetes More Prevalent in Bilateral Than Unilateral PA: A Large, Multicenter Cohort Study in Japan
Diabetes Care 42:938-945, 2019
Nagasawa M, Yamamoto K, Rakugi H, Takeda M, Akasaka H, Umakoshi H, Tsuiki M, Takeda Y, Kurihara I, Itoh H, Ichijo T, Katabami T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M,Inagaki N, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Ogo A, Okamura S, Miyauchi S, Yanase T, Suzuki T, Kawamura T, and Naruse M, JPAS Study Group Influence of antihypertensive drugs in the subtype diagnosis of primary aldosteronism by adrenal venous sampling
J Hypertens 37:1493-1499, 2019
Takai M, Ishikawa M, Maeda H, Kanamori A, Kubota A, Amemiya H, Iizuka T, Iemitsu K, Iwasaki T, Uehara G, Umezawa S, Obana M, Kaneshige H, Kaneshiro M, Kawata T, Sasai N, Saito T, Takuma T, Takeda H, Tanaka K, Nakajima S, Hoshino K, Honda S, Machimura H, Matoba K, Minagawa F, Minami N, Miyairi Y, Mokubo A, Motomiya T, Waseda M, Miyakawa M, Terauchi Y, Tanaka Y, Matsuba I Efficacy and Safety of Adding Sitagliptin in Type 2 Diabetes Patients on Insulin: Age-Stratified Comparison at One Year in the ASSIST-K Study
J Clin Med Res 11:311-320, 2019
2018年
Kobayashi H, Abe M, Soma M, Takeda Y, Kurihara I, Itoh H, Umakoshi H, Tsuiki M, Katabami T, Ichijo T, Wada N, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Shibata H, Kamemura K, Yanase T, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Nanba K, Tanabe A, Suzuki T, Naruse M; JPAS Study Group. Development and validation of subtype prediction scores for the workup of primary aldosteronism.
J Hypertens 36:2269-2276, 2018
Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, Kurihara I, Umakoshi H, Ichijo T, Katabami T, Wada N, Ogawa Y, Yoshimoto T, Kawashima J, Watanabe M, Matsuda Y, Kobayashi H, Shibata H,Miyauchi S, Kamemura K, Fukuoka T, Yamamoto K, Otsuki M, Suzuki T, Naruse M; JPAS Study Group. Obesity as a Key Factor Underlying Idiopathic Hyperaldosteronism
J Clin Endocrinol Metab 103:4456-4464, 2018
Takeda M, Yamamoto K, Akasaka H, Rakugi H, Naruse M, Takeda Y, Kurihara I, Itoh H, Umakoshi H,Tsuiki M, Ichijo T, Katabami T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Ogo A, Okamura S, Miyauchi S, Yanase T, Suzuki T, Kawamura T; JPAS Study Group. Clinical Characteristics and Postoperative Outcomes of Primary Aldosteronism in the Elderly
J Clin Endocrinol Metab 103:3620-3629, 2018
Umakoshi H, Tsuiki M, Yokomoto-Umakoshi M, Takeda Y, Takashi Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ashida K, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamto K, Ogo A, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Yanase T, Hashimoto S, Yamada M, Yoshikawa Y, Kai T, Suzuki T, Kawamura T, Naruse M. Correlation Between Lateralization Index of Adrenal Venous Sampling and Standardized Outcome in Primary Aldosteronism
J Endocr Soc 2:893-902, 2018
Nagai Y, Nishine A, Hashimoto E, Nakayama T, Sasaki Y, Murakami M, Ishii S, Kato H, Tanaka Y Efficacy and safety of switching from basal insulin to once-daily insulin degludec/insulin aspart in Japanese patients with inadequately controlled type 2 diabetese: A 4-week, randomized, open-label, treat-to-target study
J Diabetes Investig 9:567-572, 2018
Murakami M, Nagai Y, Tenjin A, Tanaka Y Proposed cut-off value of CA19-9 for detecting pancreatic cancer in patients with diabetes: a case-control study
Endocr J 65:639-643, 2018
Shibayama Y, Wada N, Naruse M, Kurihara I, Ito H, Yoneda T, Takeda Y, Umakoshi H, Tsuiki M, Ichijo T, Fukuda H, Katabami T, Yoshimoto T, Ogawa Y, Kawashima J, Ohno Y, Sone M, Fujita M, Takahashi K, Shibata H, Kamemura K, Fujii Y, Yamamoto K, Suzuki T The Occurrence of Apparent Bilateral Aldosterone Suppression in Adrenal Vein Sampling for Primary Aldosteronism
J Endocr Soc 2:398-407, 2018
Yanase T, Oki Y, Katabami T, Otsuki M, Kageyama K, Tanaka T, Kawate H, Tanabe M, Doi M, Akehi Y,Ichijo T New diagnostic criteria of adrenal subclinical Cushing’s syndrome: opinion from the Japan Endocrine Society
Endocr J 65:383-393, 2018
Umakoshi H, Ogasawara T, Takeda Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y,obayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamto K, Ogo A, Yanase T, Okamura S,Miyauchi S, Suzuki T, Tsuiki M, Naruse M; JPAS Study Group Accuracy of adrenal computed tomography in predicting the unilateral subtype in young patients with hypokalaemia and elevation of aldosterone in primary aldosteronism
Clin Endocrinol (Oxf). 88:645-651, 2018
Matsuba R, Matsuba I, Shimokawa M, Nagai Y, Tanaka Y Tofogliflozin decreases body fat mass and improves peripheral insulin resistance
Diabetes Obes Metab 20:1311-1315, 2018
Matsuba I, Matsuba R, Ishibashi S, Yamashita S, Arai H, Yokote K, Suganami H, Araki E Effects of a novel selective peroxisome proliferator-activated receptor α modulator, pemafibrate, on hepatic and peripheral glucose uptake in patients with hypertriglyceridemia and insulin resistance
J Diabetes Investig 9:1323-1332, 2018
Ikuno M, Yamada T, Shinjo Y, Morimoto T, Kumano R, Yagihashi K, Katabami T, Nakajima Y Selective venous sampling supports localization of adenoma in primary hyperparathyroidism
Acta Radiol Open 7:1-9, 2018
Naruse M, Satoh F, Tanabe A, Okamoto T, Ichihara A, Tsuiki M, Katabami T, Nomura M, Tanaka T,Matsuda T, Imai T, Yamada M, Harada T, Kawata N, Takekoshi K Efficacy and safety of metyrosine in pheochromocytoma/paraganglioma: a multi-center trial in Japan
Endocr J 65:359-371, 2018
Umakoshi H, Tsuiki M, Takeda Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Yanase T, Suzuki T, Naruse M, JPAS Study Group Significance of Computed Tomograpy and Serum Potassium in Predicting Subtype Diagnosis of Primary Aldosteronism
J Clin Endocrinol Metab 103:900-908, 2018
Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, Kurihara I, Itoh H, Umakoshi H, Tsuiki M, Ichijo T, Katabami T, Tanaka Y, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Yoneda T, Hashimoto S, Yanase T, Suzuki T, Kawamura T, Tabara Y, Naruse M; Nagahama Study; JPAS Study Group. Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan
Hypertension 71:530-537, 2018
2017年
Sasaki Y, Katabami T, Asai S, Fukuda H, Tanaka Y In the overnight dexamethasone suppression test, 1.0 mg loading is superior to 0.5 mg loading for diagnosing subclinical adrenal Cushing’s syndrome based on plasma dexamethasone levels determined using liquid chromatography-tandem mass spectrometry
Endocr J 64:833-842, 2017
Ohta A, Kato H, Ishii S, Sasaki Y, Nakamura Y, Nakagawa T, Nagai Y, Tanaka Y Ipragliflozin, a sodium glucose co-transporter 2 inhibitor, reduces intrahepatic lipid content and abdominal visceral fat volume in patients with type 2 diabetes
Expert Opin Pharmacother 18:1433-1438, 2017
Iemitsu K, Kawata T, Iizuka T, Takihata M, Takai M, Nakajima S, Minami N, Umezawa S, Kanamori A, Takeda H, Ito S, Kikuchi T, Amemiya H, Kaneshiro M, Mokubo A, Takuma T, Machimura H, Tanaka K, Asakura T, Kubota A, Aoyanagi S, Hoshino K, Ishikawa M, Matsuzawa Y, Obana M, Sasai N, Kaneshige H, Minagawa F, Saito T, Shinoda K, Miyakawa M, Tanaka Y, Terauchi Y, Matsuba I Effectiveness of Ipragliflozin for Reducing Hemoglobin A1c in Patients With a Shorter Type 2 Diabetes Duration: Interim Report of the ASSIGN-K Study
J Clin Med Res 9:793-801, 2017
Yamada T, Ikuno M, Shinjo Y, Hiroishi A, Matsushita S, Morimoto T, Kumano R, Yagihashi K, Katabami T Selective venous sampling for primary hyperparathyroidism: how to perform an examination and interpret the results with reference to thyroid vein anatomy
Jpn J Radiol 35:409-416, 2017
Kawata T, Iizuka T, Iemitsu K, Takihata M, Takai M, Nakajima S, Minami N, Umezawa S, Kanamori A, Takeda H, Ito S, Kikuchi T, Amemiya H, Kaneshiro M, Mokubo A, Takuma T, Machimura H, Tanaka K, Asakura T, Kubota A, Aoyanagi S, Hoshino K, Ishikawa M, Matsuzawa Y, Obana M, Sasai N, Kaneshige H, Minagawa F, Saito T, Shinoda K, Miyakawa M, Tanaka Y, Terauchi Y, Matsuba I Ipragliflozin Improves Glycemic Control and Decreases Body Fat in Patients With Type 2 Diabetes Mellitus
J Clin Med Res 9:586-595, 2017
Ohta A, Kato H, Ishii S, Nagai Y, Tanaka Y Effect of Ezetimibe Monotherapy on Low-Density Lipoprotein Cholesterol and on Markers of Cholesterol Synthesis and Absorption in Japanese Patients With Hypercholesterolemia
J Clin Med Res 9:476-481, 2017
Nakayama T, Nagai Y, Uehara Y, Nakamura Y, Ishii S, Kato H, Tanaka Y Eating glutinous brown rice twice a day for 8 weeks improves glycemic control in Japanese patients with diabetes mellitusNutr Diabetes 7:e273, 2017
Terashima Y, Nagai Y, Kato H, Ohta A, Tanaka Y Eating glutinous brown rice for one day improves glycemic control in Japanese patients with type 2 diabetes assessed by continuous glucose monitoring
Asia Pac J Clin Nutr 26:421-426, 2017
Asai S, Katabami T, Tsuiki M, Tanaka Y, Naruse M Controlling Tumor Progression with Cyclophosphamide, Vincristine, and Dacarbazine Treatment Improves Survival in Patients with Metastatic and Unresectable Malignant Pheochromocytomas/Paragangliomas
Horm Cancer 8:108-118, 2017
Nagai Y, Ohta A, Sada Y, Kato H, Tanaka Y Effect of 24-week treatment with ipragliflozin on proinsulin/C-peptide ratio in Japanese patients with type 2 diabetes
Expert Opin Pharmacother 18:13-17, 2017
2016年
Yanase T, Tajima T, Katabami T, Iwasaki Y, Tanahashi Y, Sugawara A, Hasegawa T, Mune T, Oki Y, Nakagawa Y, Miyamura N, Shimizu C, Otsuki M, Nomura M, Akehi Y, Tanabe M, Kasayama S Diagnosis and treatment of adrenal insufficiency including adrenal crisis: a japan Endocrine Society clinical practice guideline[Opinion]
Endocr J 63:765-784, 2016
Uzu T, Araki S, Kashiwagi A, Haneda M, Koya D, Yokoyama H, Kida Y, Ikebuchi M, Nakamura T,Nishimura M, Takahara N, Obata T, Omichi N, Sakamoto K, Shingu R, Taki H, Nagai Y, Tokuda H, Kitada M, Misawa M, Nishiyama A, Kobori H, Maegawa H, The Shiga Committee for Preventing Diabetic Nephropathy Comparative Effects of Direct Renin Inhibitor and Angiotensin Receptor Blocker on Albuminuria in Hypertensive Patients with Type 2 Diabetes. A Randomized Controlled Trial
PLOS ONE 11: e0164936, 2016
Nemoto K, Ugi S, Ogaku S, Nakaizumi N, Kato T, Fuse K, Sekine O, Morino K, Tanaka T, Maegawa H A case of local delayed-type allergy to zinc-containing insulin as a cause of diabetic ketoacidosis in a patient with type 1 diabetes mellitus undergoing continuous subcutaneous insulin infusion
Diabetol Int 7: 447-450, 2016
Katabami T, Ishii S, Obi R, Asai S, Tanaka Y Contralateral adrenal suppression on adrenocortical scintigraphy provides good evidence showing subclinical cortisol overproduction from unilateral adenomas
Endocr J 63:1123-1132, 2016
Nagai Y, Murakami M, Igarashi K, Nakamura Y, Tsukiyama H, Matsubara F, Nishine A, Ohshige T, Ishii S, Kato H, Tanaka Y Efficacy and safety of thrice-weekly insulin degludec in elderly patients with type 2 diabetes assessed by continuous glucose monitoring
Endocr J 63:1099-1106, 2016
Matsubara F, Nagai Y, Tsukiyama H, Shimizu H, Yamanouchi E, Iwamoto T, Sada Y, Kato H, Ohta A,Tanaka Y Proposed cut-off value of the intrahepatic lipid content for metabolically normal persons assessed by proton magnetic resonance spectroscopy in a Japanese population
Diabetes Res Clin Pract 119: 75-82, 2016
Tsukiyama H, Nagai Y, Matsubara F, Shimizu H, Iwamoto T, Yamanouchi E, Sada Y, Kato H, Ohta A,Tanaka Y Proposed cut-off values of the waist circumference for metabolic syndrome based on visceral fat volume in a Japanese population
J Diabetes Investig 7: 587-593, 2016
Iemitsu K, Iizuka T, Takihata M, Takai M, Nakajima S, Minami N, Umezawa S, Kanamori A, Takeda H, Kawata T, Ito S, Kikuchi T, Amemiya H, Kaneshiro M, Mokubo A, Takuma T, Machimura H, Tanaka K, Asakura T, Kubota A, Aoyagi S, Hoshino K, Ishikawa M, Obana M, Sasai N, Kaneshige H, Miyakawa M, Tanaka Y, Terauchi Y, Matsuba I Factors Influencing Changes in Hemoglobin A1c and Body Weight During Treatment of Type 2 Diabetes With Ipragliflozin: Interim Analysis of the ASSIGN-K Study
J Clin Med Res 8: 373-378, 2016
Yuasa S, Sato K, Takai M, Ishikawa M, Umezawa S, Kubota A, Maeda H, Kanamori A, Miyakawa M,Tanaka Y, Terauchi Y, Matsuba I Factor Analysis of Changes in Hemoglobin A1c After 12 Months of Sitagliptin Therapy in Patients With Type 2 Diabetes
J Clin Med Res 8: 461-471, 2016
Iizuka T, Iemitsu K, Takihata M, Takai M, Nakajima S, Minami N, Umezawa S, Kanamori A, Takeda H, Kawata T, Ito S, Kikuchi T, Amemiya H, Kaneshiro M, Mokubo A, Takuma T, Machimura H, Tanaka K, Asakura T, Kubota A, Aoyagi S, Hoshino K, Ishikawa M, Matsuzawa Y, Obana M, Sasai N, Kaneshige H, Minagawa F, Saito T, Shinoda K, Miyakawa M, Tanaka Y, Terauchi Y, Matsuba I Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study
J Clin Med Res 8: 116-125, 2016
Imamura M, Takahashi A, Yamauchi T, Hara K, Yasuda K, Grarup N, Zhao W, Wang X, Huerta-Chagoya A, Hu C, Moon S, Long J, Kwak SH, Rasheed A, Saxena R, Ma RC, Okada Y, Iwata M, Hosoe J, Shojima N, Iwasaki M, Fujita H, Suzuki K, Danesh J, Jørgensen T, Jørgensen ME, Witte DR, Brandslund I, Christensen C, Hansen T, Mercader JM, Flannick J, Moreno-Macías H, Burtt NP, Zhang R, Kim YJ, Zheng W, Singh JR, Tam CH, Hirose H, Maegawa H, Ito C, Kaku K, Watada H, Tanaka Y, Tobe K, Kawamori R, Kubo M, Cho YS, Chan JC, Sanghera D, Frossard P, Park KS, Shu XO, Kim BJ, Florez JC, Tusié-Luna T, Jia W, Tai ES, Pedersen O, Saleheen D, Maeda S, Kadowaki T Genome-wide association studies in the Japanese population identify seven novel loci for type 2 diabetes
Nat Commun 2016, in press
Matsuba R, Imamura M, Tanaka Y, Iwata M, Hirose H, Kaku K, Maegawa H, Watada H, Tobe K, Kashiwagi A, Kawamori R, Maeda S Replication Study in a Japanese Population of Six Susceptibility Loci for Type 2 Diabetes Originally Identified by a Transethnic Meta-Analysis of Genome-Wide Association Studies
PLOS ONE 11: e0154093, 2016
Tenjin A, Nagai Y, Yuji S, Ishii S, Kato H, Ohta A, Tanaka Y Short-term change of carotid intima-media thickness after treatment of hyperglycemia in patients with diabetes: a cross -sectional study
BMC Res Notes 9: 281, 2016
Matsubara F, Katabami T, Asai S, Ariizumi Y, Maeda I, Takagi M, M McNamara K, Ono K, Maekawa T, Nakamura Y, Tanaka Y, Sasano H Immunohistochemical analysis of insulin-like growth factor 1 and its receptor in sporadic schwannoma/peripheral nerve sheath tumour
J Int Med Res 44: 662-672, 2016
2015年
Maeda H, Kubota A, Kanamori A, Tanaka Y, Terauchi Y, Matsuba I, Study Group of Diabetes Committee, Kanagawa Physicians Association Effects of sitagliptin on the serum creatinine in Japanese type 2 diabetes
Diabetes Res Clin Pract 108: e42-45, 2015
Nakamura Y, Nagai Y, Terashima Y, Nishine A, Ishii S, Kato H, Ohta A, Tanaka Y Better response to the SGLT2 inhibitor dapagliflozin in young adults with type 2 diabetes
Expert Opin Pharmacother 16: 2553-2559, 2015
Matsuba R, Sakai K, Imamura M, Tanaka Y, Iwata M, Hirose H, Kaku K, Maegawa H, Watada H, Tobe K, Kashiwagi A, Kawamori R, Maeda S Replication Study in a Japanese Population to Evaluate the Association between 10 SNP Loci, Identified in European Genome-Wide Association Studies, and Type 2 Diabetes
PLOS ONE 10: e0126363, 2015
Kato H, Nagai Y, Ohta A, Tenjin A, Nakamura Y, Tsukiyama H, Sasaki Y, Fukuda H, Ohshige T, Terashima Y, Sada Y, Kondo A, Sasaoka T, Tanaka Y Effect of sitagliptin on intrahepatic lipid content and body fat in patients with type 2 diabetes
Diabetes Res Clin Pract 109: 199-205, 2015
Umakoshi H, Tanase-Nakao K, Wada N, Ichijo T, Sone M, Inagaki N, Katabami T, Kamemura K, Matsuda Y, Fujii Y, Kai T, Fukuoka T, Sakamoto R, Ogo A, Suzuki T, Tsuiki M, Shimatsu A, Naruse M Importance of contralateral aldosterone suppression during adrenal vein sampling in the subtype evaluation of primary aldosteronism.
Clin Endocrinol (Oxf) 83: 462-467, 2015
2014年
Kawata T, Kanamori A, Kubota A, Maeda H, Amamiya H, Takai M, Kaneshige H, Minagawa F, Iemitsu K, Kaneshiro M, Ishikawa M, Takeda H, Takuma T, Mokubo A, Machimura H, Obana M, Miyakawa M, Naka Y, Terauchi Y, Toyoda M, Suzuki D, Tanaka Y, Matsuba I Clinical effects of liraglutide on diabetes control in Japanese type 2 diabetes mellitus patients
Diabetol Int 5: 98-104, 2014
Asai S, Ohta A, Kato H, Sada Y, Nagai Y, Kondo A, Sasaoka T, Tanaka Y Effect of sitagliptin on glycemic control and beta cell function in Japanese patients given basal-supported oral therapy for type 2 diabetes
Endocr J 61: 1213-1220, 2014
Tanase-Nakao K, Naruse M, Nanba K, Tsuiki M, Tagami T, Usui T, Okuno H, Shimatsu A, Hashimoto S, Katabami T, Ogo A, Okumura A, Umakoshi H, Suzuki T Chronic kidney disease score for predicting postoperative masked renal insufficiency in patients with primary aldosteronism
Clin Endocrinol (Oxf) 81: 665-670, 2014
Kawashima ST, Usui T, Tenjin A, Asai S, Tanaka Y, Hoshikawa M, Shimatsu A, Katabami T AIn Silico Analysis Identification of a Novel Germ-Line VHL Mutation in a Patient of Malignant Pheochromocytoma Endocr Pract 20: e96-e101, 2014
Katabami T, Murakami M, Kobayashi S, Matsui T, Ujihara M, Takagi S, Higa M, Ichijo T, Ohta A, Tanaka Y Efficacy of low-dose rosuvastatin in patients with type 2 diabetes and hypo high-density lipoprotein cholesterolemia J Int Med Res 42: 457-467, 2014
Pheochromocytoma Study Group in Japan, Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T, Kakoi N, Rakugi H, Ikeda Y, Tanabe A, Nigawara T, Ito S, Kimura I, Naruse M Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma Endocr Relat Cancer 21: 405-414, 2014
Takai M, Ishikawa M, Maeda H, Kanamori A, Kubota A, Amemiya H, Iizuka T, Iemitsu K, Iwasaki T,
Uehara G, Umezawa S, Obana M, Kaneshige H, Kaneshiro M, Kawata T, Sasai N, Saito T, Takuma T, Takeda H, Tanaka K, Tsurui N, Nakajima S, Hoshino K, Honda S, Machimura H, Matoba K, MInagawa F, Minami N, Miyairi Y, Mokubo A, Motomiya T, Waseda M, Miyakawa M, Naka Y, Terauchi Y, Tanaka Y, Matsuba I Safety and efficacy of adding sitagliptin to insulin in patients with type 2 diabetes: The ASSIST-K study
Diabetes Res Clin Pract 103: e30-3, 2014
Ohta A , Kato H, Murayama K, Hashimoto E, Murakami M, Nishine A, Ohshige T, Sada Y, Asai S, Kawata T, Nagai Y, Katabami T, Tanaka Y Effect of insulin glargine on endogenous insulin secretion and beta-cell function in Japanese type 2 diabetic patients using oral antidiabetic drugs
Endocr J 61: 13-18, 2014
Nagai Y, Hashimoto E, Oikawa R, Asai S, Terashima Y, Nakamura Y, Sasaki Y, Tsukiyama H, Fukuda H, Ohshige T, Kato H, Ohta A, Tanaka Y Differing effects of liraglutide on gastric emptying in Japanese patients with type 2 diabetes
Diabetes Obes Metab 16: 573-576, 2014
Kawata T, Kanamori A, Kubota A, Maeda H, Amemiya H, Takai M, Kaneshige H, Minagawa F, Iemitsu K, Kaneshiro M, Ishikawa M, Takeda H, Takuma T, Mokubo A, Machimura H, Obana M, Miyakawa M, Naka Y, Suzuki D, Terauchi Y, Toyoda M, Tanaka Y, Matsuba I Is a switch from insulin therapy to liraglutide possible in Japanese type 2 diabetes mellitus patients?
J Clin Med Res 6: 138-144, 2014
Miyake Y, Tanaka K, Nishikawa T, Naruse M, Takayanagi R, Sasano H, Takeda Y, Shibata H, Sone M, Sato F, Yamada M, Ueshiba H, Katabami T, Iwasaki Y, Tanaka H, Tanahashi Y, Suzuki S, Hasegawa T, Katsumata N, Tajima T, Yanase T Prognosis of primary aldosteronism in Japan: results from a nationwide epidemiological study
Endocr J 61: 35-40, 2014
2013年
Ohta A, Arai K, Nishine A, Sada Y, Kato H, Fukuda H, Asai S, Nagai Y, Katabami T, Tanaka Y Comparison of daily glucose excursion by continuous glucose monitoring between type 2 diabetic receiving preprandial insulin aspart or postprandial insulin glulisine Endocr J 60: 173-177, 2013
Nanba K, Tsuiki M, Sawai K, Mukai K, Nishimoto K, Usui T, Tagami T, Okuno H, Yamamoto T, Shimatsu A, Katabami T, Okumura A, Kawa G, Tanabe A, Naruse M Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry
J Clin Endocrinol Metab 98: 1567-1574, 2013
Ohta A, Kato H, Nakamura Y, Tenjin A, Sakai K, Tukiyama H, Terashima Y, Nagai Y, Tanaka Y Cold-loaded pain sensation test and current perception threshold for evaluation of diabetic neuropathy
Diabetol Int 4: 34-39, 2013
Nagai Y, Ohshige T, Arai K, Kobayashi H, Sada Y, Omori S, Furukawa K, Kato H, Kawata T, Ohta A,Tanaka Y Comparison between shorter straight and thinner microtapered insulin Injection needles
Diabetes Technol Ther 15: 550-555, 2013
Fukuda H, Imamura M, Tanaka Y, Iwata M, Hirose H, Kaku K, Maegawa H, Watada H, Tobe K, Kashiwagi A, Kawamori R, Maeda S Replication study for the association of a single-nucleotide polymorphism, rs3746876,within KCNJ15, with susceptibility to type 2 diabetes in a Japanese population J Human Genet 58: 490-493, 2013
Ohta A, Ohshige T, Sakai K, Nakamura Y, Tenjin A, Tsukiyama S, Terashima Y, Matsubara F, Kawata T, Nagai Y, Tanaka Y Comparison of the hypoglycemic effect of sitagliptin versus the combination of mitiglinide and voglibose in drug-naïve Japanese patients with type 2 diabetes Expert Opin Pharmacother 14: 2315-2322, 2013
Erion MD, Popov V, Hsiao JJ, Vatner D, Mitchell K, Yonemitsu S, Nagai Y, Kahn M, Gillum PM, Dong J, Murray FS, Manchem PV, Bhanot S, Cline WG, Shulman IG, Samuel T The role of the carbohydrate response element-binding protein in male fructose-fed rats
Endocrinology 154: 36-44, 2013
Imamura M, Iwata M, Maegawa H, Watada H, Hirose H, Tanaka Y, Tobe K, Kaku K, Kashiwagi A,Kadowaki T, Kawamori R, Maeda S Replication study for association of rs391300 in SRR and rs17584499 in PTPRD with susceptibility to type 2 diabetes in a Japanese population J Diabetes Invest 4: 168-173, 2013
Kawata T, Ohta A, Nemoto T, Nishisako H, Yamasaki Y, Hirose M, Kunishima H, Matsuda T, Tanaka Y A Case of Slowly Progressive Insulin-dependent Diabetes Mellitus (SPIDDM) with Low Anti-GAD Antibody Titer Detected during Treatment of Organizing Pneumonia General Med 14: 1-5, 2013
Maeda H, Kubota A, Kanamori A, Tanaka Y, Terauchi Y, Matsuba I, ASSET-K Study Group Long-term efficacy and safety of sitagliptin in the treatment of Japanese Type 2 diabetes (ASSET-K1) to a target of HbA1c ＜7％
J Endocrinol Invest 36: 568-573, 2013
2012年
Kubota A, Maeda H, Kanamori A, Matoba K, Jin Y, Minagawa F, Obana M, lemitsu K, Ito S, Amemiya H, Kaneshiro M, Takai Masahiko, Kanesige H, Hoshino K, Ishikawa M, Minami N, Takuma T, Sasai N,
Aoyagi S, Kawata T, Mokubo A, Takeda H, Honda S, Machimura H, Motomiya T, Waseda M, Naka Y,Tanaka Y, Terauchi Y, Matsuba I Pleiotropic Effects of Sitagliptin in the Treatment of Type 2 Diabetes Mellitus Patients
J Clin Med Res 4: 309-313, 2012
Maeda H, Kubota A, Tanaka Y, Terauchi Y, Matsuba I, ASSET-K Study Group The safety, efficacy and predictors for HbA1c reduction of sitagliptin in the treatment of Japanese type 2 diabetes
Diabetes Res Clin Pract 95: 20-22, 2012
Kato H, Ohta A, Kobayashi S, Ishii S, Sada Y, Kobayashi H, Omori S, Kondo A, Katabami T, Fuse J,Fukuda H, Nagai Y, Tanaka Y Effect of the α-glucosidase inhibitor miglitol on the glucose profile in Japanese type 2 diabetic patients receiving multiple daily insulin injections
Endocr J 59: 345-352, 2012
Sakurai A, Suzuki S, Kosugi S, Okamoto T, Uchino S, Miya A, Imai T, Kaji H, Komoto I, Miura D, Yamada M, Uruno T, Horiuchi K, Miyauchi A, Imamura M; MEN Consortium of Japan, Fukushima T, Hanazaki K, Hirakawa S, Igarashi T, Iwatani T, Kammori M, Katabami T, Katai M, Kikumori T, Kiribayashi K, Koizumi S, Midorikawa S, Miyabe R, Munekage T, Ozawa A, Shimizu K, Sugitani I, Takeyama H, Yamazaki M Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database
Clin Endocrinology 76: 533-539, 2012
Miyauchi K, Yamazaki T, Watada H, Tanaka Y, Kawamori R, Imai Y, Ikeda S, Kitagawa A, Ono Y,Murayama F, Choi BJ, Suwa S, Hayashi D, Kishimoto J, Daida H; for the ADVANCED-J investigators Management of home blood pressure by amlodipine combined with angiotensin II receptor blocker in type 2 diabetes
Circulation J 76: 2159-2166, 2012
Imamura M, Maeda S, Yamauchi T, Hara K, Yasuda K, Morizono T, Takahashi A, Horikoshi M, Nakamura M, Fujita H, Tsunoda T, Kubo M, Watada H, Maegawa H, Okada IM, Iwabu M, Shojima N, Ohshige T, Omori S, Iwata M, Hirose H, Kaku K, Ito C, Tanaka Y, Tobe K, Kashiwagi A, Kawamori R, Kasuga M, Kamatani N; Diabetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium, Nakamura Y, Kadowaki T A single-nucleotide polymorphism in ANK1 is associated with susceptibility to type 2 diabetes in Japanese populations
Human Molecular Genet 121: 3042-3049, 2012
Kondo A, Ohta A, Kato H, Matsubara F, Fukuda H, Kobayashi H, Kawata T, Tanaka Y Effect of combination therapy with losartan and low-dose hydrochlorothiazide for albuminuria on the patients with type 2 diabetes mellitus
Japanese J Clin Physiol 42: 89-95, 2012
Fukuda H, Imamura M, Tanaka Y, Iwata M, Hirose H, Kaku K, Maegawa H, Watada H, Tobe K, Kashiwagi A, Kawamori R, Maeda S A Single nucleotide polymorphism within DUSP9 Is associated with susceptibility to type 2 diabetes in a Japanese population
PLoS One 7: e46263, 2012
Kawata T, Kanamori A, Kubota A, Maeda H, Matoba K, Ito S, Amamiya H, Takai M, Kaneshige H, Minami N, Minagawa F, Iemitsu K, Ishikawa M, Hoshino K, Miyakawa M, Naka Y, Toyoda M, Terauchi Y, Suzuki D, Tanaka Y, Matsuba I Efficacy and safety of liraglutide in patients with type2 diabetes:the SEDIK study
J Diabetes Invest 3: 203, 2012
Sato T, Katabami T, Furukawa K, Narimatsu H, Hashimoto T, Nakajima Y, Ohta A, Sasaoka T, Tanaka Y Intracellular lipid content of liver and skeletal muscle in patients with adult growth hormone deficiency without diabetes mellitus
Obesity Res Clin Pract 6: e321-e329, 2012
2011年
Kamijo IA, Sugaya T, Yasuda T, Kawata T, Ohta A, Tatsunami S, Kaise R, Ishimitsu T, Tanaka Y, Kimura K Clinical significance of urinary liver-type fatty acid- binding protein in diabetic nephropathy of type 2 diabetic patients Diabetes Care 34: 691-696, 2011
Sada Y, Katabami T, Asai S, Sato T, Furukawa K, Ishii S, Kato H, Kobayashi H, Kondo A, Ohta A, Nakajima Y, Tanaka Y Intrahepatic lipid content is linked to insulin resistance in obese subjects
Obesity Res Clin Pract 5: e129-e136, 2011
Ohshige T, Iwata M, Omori S, Tanaka Y, Hirose H, Kaku K, Maegawa H, Watada H, Kashiwagi A,Kawamori R, Tobe K, Kadowaki T, Nakamura Y, Maeda S Association of new loci Identified in European genome-wide association studies with susceptibility to type 2 diabetes in the JapanesePLoS One 6: e26911, 2011
Imamura M, Iwata M, Maegawa H, Watada H, Hirose H, Tanaka Y, Tobe K, Kaku K, Kashiwagi A,Kawamori R, Nakamura Y, Maeda S Genetic variants at CDC123/CAMK1D and SPRY2 are associated with susceptibility to type 2 diabetes in the Japanese population Diabetologia 54: 3071-3077, 2011
Ohta A, Suwa T, Sada Y, Kato H, Koganei R, Asai S, Katabami T, Tanaka Y Comparison of daily glucose excursion by continuous glucose monitoring between type 2 diabetic patients receiving biphasic insulin aspart 30 or biphasic human insulin 30
J Diabetes Invest 2: 406-411, 2011
2010年
Ohshige T, Tanaka Y, Araki S, Babazono T, Toyoda M, Umezono T, Watada H, Suzuki D, Iwamoto Y, Kawamori R, Nakamura Y, Maeda S A single nucleotide polymorphism in KCNQ1 Is associated with susceptibility to diabetic nephropathy in Japanese subjects with type 2 diabetes
Diabetes Care 33: 842-846, 2010
Suwa T, Ohta A, Matsui T, Koganei R, Kato H, Kawata T, Sada Y, Ishii S, Kondo A, Murakami K, Katabami T, Tanaka Y Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM)
Endocr J 57: 135-140, 2010
Katabami T, Kato H, Asahina T, Hinohara S, Shin T, Kawata T, Ohta A, Iwamoto T, Tanaka Y Serum free testosterone and metabolic syndrome in Japanese men
Endocr J 57: 533-539, 2010
Furukawa K, Katabami T, Nakajima Y, Sato T, Kato H, Koganai R, Asai S, Matsui T, Sada Y, Kawata T, Kondo A, Ohta A, Tanaka Y Evaluation of whole-abdominal fat volume by 700-slice CT scanning and comparison with the umbilical fat area anthropometric indices
Obesity Res Clin Pract 4: e111-e117, 2010
Yamauchi T, Hara K, Maeda S, Yasuda K, Takahashi A, Horikoshi,M Nakamura M, Fujita H, Grarup N, Cauchi S, Daniel PKN, Ronald CWM, Tsunoda T, Kudo M, Watada H, Maegawa H, Okada IM, Iwabu M, Shojima N, Shin DH, Andersen G, Witte RD, Jorgensen T, Lauritzen T, Sandbaek A, Hansen T, Ohshige T, Omori S, Saito I, Kaku K, Hirose H, So WY, Beury D, Chan CNJ, Park SK, Tail SE, Ito C, Tanaka Y, Kashiwagi A, Kawamori R, Kasuga M, Froguel P, Pedersen O, Kamatani N, Nakamura Y, Kadowaki T A genome wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B
Nature Genet 42: 864-868, 2010
2009年
Ohmura C, Watada H, Azuma K, Shimizu T, Kanazawa A, Ikeda F, Yoshihara T, Fujitani Y, Hirose T,Tanaka Y, Kawamori R Aldose reductase Inhibitor, epalrestat, reduces lipid hydroperoxides in type 2 diabetesEndocr J 56: 149-156, 2009
Asai S, Katabami T, Obi N, Matsui T, Kato H, Obi R, Ogawa Y, Kawata T, Takama H, Ohta A, Tanaka Y No ghrelin response to oral glucose in diabetes mellitus with gastroparesis
Endocr J 56: 79-87, 2009
Obi N, Katabami T, Obi R, Odanaka M, Sasano K, Tanaka Y Primary malignant hepatic glucagonoma : an autopsy case
Endocr J 56: 715-719, 2009
Tanaka Y, Daida H, Imai Y, Miyauchi K, Sato Y, Hiwatari M, Kitagawa A, Kishimoto J, Yamazaki T,Kawamori R Morning home blood pressure may be a significant marker of nephropathy in Japanese patients with type 2 diabetes ADVANCED-J study 1Hypertension Res 32: 770-774, 2009
Omori S, Tanaka Y, Horikoshi M, Takahashi A, Hara K, Hirose H, Kashiwagi A, Kaku K, Kawamori R, Kadowaki T, Nakamura Y, Maeda S Replication study for the association of new meta-analysis-derived risk loci with susceptibility to type 2 diabetes in 6,244 Japanese individuals
Diabetologia 52: 1554-1560, 2009
2008年
Tamura Y, Watada H, Igarashi Y, Nomiyama T, Onishi T, Takahashi K, Doi S, Katamoto S, Hirose T, Tanaka Y, Kawamori R Short-term effects of dietary fat on intramyocellular lipid in sprinters and endurance runners.
Metabolism 57: 373-379, 2008
Tamura Y, Watada H, Sato F, Kumashiro N, Sakurai Y, Hirose T, Tanaka Y, Kawamori R Effects of metformin on peripheral Insulin sensitivity and intracellular lipid contents in muscle and liver of overweight Japanese subjects
Diabetes Obesity Metab 10: 733-738, 2008
Obi N, Katabami T, Asai S, Saito N, Tanaka Y Fulminant Type 1 diabetes complicated by leukemoid reaction Intern Med 47: 847-851, 2008
Amano T, Imano T, Takemae K, Iwamoto T, Yamanaka K, Baba K, Nakanome M, Sugimori H, Tanaka Y, Yoshida K, Katabami T, Tanaka M Profile of serum testosterone levels after application of testosterone ointment (glowmin) and Its clinical efficacy in late-onset hypogonadism patients
J Sex Med 5: 1727-1736, 2008
2007年
Tamura Y, Ogihara T, Uchida T, Ikeda F, Kumashiro N, Nomiyama T, Sato F, Hirose T, Tanaka Y, Mochizuki H, Kawamori R, Watada H Amelioration of glucose tolerance by hepatic inhibition of nuclear factor kappab in db/db mice
Diabetologia 50: 131-141, 2007
Sugai M, Ohta A, Ogata Y, Nakanishi M, Ueno S, Kawata T, Saito N, Tanaka Y Asymmetric dimethylarginine(ADMA) in the anqueous humor of diabetic patients
Endocr J 54: 303-309, 2007
Nakaniwa T, Nomiyama T, Takahashi S, Sakai K, Uchino H, Shimizu T, Kanazawa A, Watada H, Hirose T, Kawamori R, Tanaka Y Manganese superoxide dismutase polymorphism (V16A) associated with inpaired cardiac autonomic function in Japanese type 2 deiabetid patients.
Jpn J Clin Physiol 37: 27-34, 2007
Ohta A, Omori S, Obi R, Tanaka Y Penile necrosis by calciphylaxis in a diabetic patient with chronic renal failure
Internal Med 46: 985-990, 2007
Kumashiro N, Yoshihara T, Kanazawa Y, Shimizu T, Watada H, Tanaka Y, Fujitani Y, Kawamori R, Hirose T Long-term effect of combination therapy with mitiglinide and once daily Insulin glargine in patients who were succesfully switched from Intensive Insulin therapy in short-term study
Endocr J 54: 163-166, 2007
Sato F, Tamura Y, Watada H, Kumashiro N, Igarashi Y, Uchino H, Maehara T, Kyogoku S, Sunayama S, Sato H, Hirose T, Tanaka Y, Kawamori R Effects of diet-induced moderate weight reduction on intrahepatic and Intramyocellular triglycerides and glucose metabolism in obese subjects
J Clin Endocrinology Metab 92: 3326-3329, 2007
Ikeda F, Azuma K, Ogihara T, Toyofuku Y, Otsuka A, Mita T, Hirose T, Tanaka Y, Kawamori R, Watada H Angiotenshin Ⅱtype 1 receptor blocker reduces monocyte adhesion to endothelial cells in pontaneously hypertensive rats Endocr J 54: 605-612, 2007
Omori S, Tanaka Y, Takahashi A, Hirose H, Kashiwagi A, Kaku K, Kawamori R, Nakamura Y, Maeda S Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8 and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population
Diabetes 57: 791-795, 2007
Kanazawa Y, Igarashi Y, Komiya K, Sakurai Y, Shimizu T, Fujitani Y, Tanaka Y, Watada H, Kawamori R, Hirose T Long-term efficacy of insulin glargine after switching from NPH insulin as intensive replacement of basal insulin in Japanese diabetes mellitus. Comparison of efficacy between type 1 and type 2 diabetes (JUN-LAN Study 1).
Endocr J 54: 975-983, 2007
Mita T, Watada H, Shimizu T, Tamura Y, Sato F, Watanabe T, Choi BJ, Hirose T, Tanaka Y, Kawamori R Nateglinide reduces carotid intima-media thickening in type 2 diabetic patients under good glycemic control Arterioscler Thromb Vasc Biol 27: 2456-2462, 2007
